While several mitogenic pathways are known to be upregulated in NF2-mutant cells, despite considerable effort, there is as yet no consensus as to how loss of the NF2 tumor suppressor gene leads to schwannoma growth, nor are there effective medical therapies for this disorder. The gene discussed is NF2; the disease is schwannoma.